/ Not yet recruitingNot Applicable A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Analgesic Efficacy of Ketorolac Tromethamine Administered Intranasally for the Acute Treatment of Migraine - ROX-2007-01
100 Clinical Results associated with ROXRO Pharma, Inc.
0 Patents (Medical) associated with ROXRO Pharma, Inc.
100 Deals associated with ROXRO Pharma, Inc.
100 Translational Medicine associated with ROXRO Pharma, Inc.